Beta Bionics BBNX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$955.1K (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 50.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 16.66% to 9.16% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +8,899,611 | 16.4% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +826,477 | 2.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +456,629 | 4.1% |
| FMR | Mutual Fund | 2026/Q3 | +437,623 | 0.8% |
| TD Asset Management | Mutual Fund | 2026/Q3 | +392,422 | 0.7% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +345,160 | 0.8% |
| ING Groep N.V. | Public Company | 2026/Q3 | +250,000 | 0.5% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +190,175 | 0.3% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +179,556 | 0.3% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +167,503 | 0.3% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +86,314 | 0.2% |
| Divisadero Street Capital Management, LP | Hedge Fund | 2026/Q3 | +1,959,183 | 5.7% |
| Tri Locum Partners LP | Hedge Fund | 2026/Q3 | +493,344 | 0.9% |
| Bank of America Corporation | Public Company | 2026/Q3 | +427,742 | 1.0% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +415,426 | 1.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 10 Nov 2026 | Stephen Feider | Chief Financial Officer | Derivative Exercise and Sale | -8,874 | $17.21 | 159,378 |
| 8 Nov 2026 | Stephen Feider | Chief Financial Officer | Derivative Exercise and Sale | -744 | $17.00 | 159,378 |
| 4 Nov 2026 | Stephen Feider | Chief Financial Officer | Derivative Exercise and Sale | -382 | $17.04 | 159,378 |
| 1 Nov 2026 | Mark Hopman | Chief Commercial Officer | Automatic Disposition | -370 | $16.90 | 54,143 |
| 26 Oct 2026 | Mike Mensinger | Chief Product Officer | Automatic Disposition | -2,650 | $22.00 | 174,740 |
| 25 Oct 2026 | Mark Hopman | Chief Commercial Officer | Automatic Disposition | -821 | $20.00 | 54,513 |
| 13 Oct 2026 | Mark Hopman | Chief Commercial Officer | Automatic Disposition | -775 | $17.35 | 55,334 |
| 30 Sep 2026 | Mark Hopman | Chief Commercial Officer | Automatic Disposition | -370 | $18.96 | 56,109 |
| 21 Sep 2026 | Christina Jones | Independent Director | Automatic Disposition | -6,430 | $23.00 | 4,842 |
| 15 Sep 2026 | Mark Hopman | Chief Commercial Officer | Automatic Disposition | -30,779 | $20.13 | 56,479 |
| 15 Sep 2026 | Mike Mensinger | Chief Product Officer | Automatic Disposition | -2,650 | $22.00 | 177,390 |
| 13 Sep 2026 | Mark Hopman | Chief Commercial Officer | Automatic Disposition | -775 | $15.52 | 86,382 |
| 8 Sep 2026 | Mark Hopman | Chief Commercial Officer | Open Market Disposition | -35,994 | $18.46 | 88,033 |
| 2 Sep 2026 | Sean Saint | Chief Executive Officer | Automatic Disposition | -5,641 | $20.08 | 398,429 |
| 1 Sep 2026 | Sean Saint | Chief Executive Officer | Open Market Disposition | -16,867 | $19.11 | 404,070 |
| 1 Sep 2026 | Stephen Feider | Chief Financial Officer | Open Market Disposition | -6,675 | $19.11 | 159,378 |
| 1 Sep 2026 | Steven Russell | Chief Medical Officer | Open Market Disposition | -4,221 | $19.11 | 169,628 |
| 1 Sep 2026 | Mark Hopman | Chief Commercial Officer | Open Market Disposition | -5,327 | $19.11 | 124,027 |
| 1 Sep 2026 | Mike Mensinger | Chief Product Officer | Open Market Disposition | -4,375 | $19.11 | 180,040 |
| 28 Jun 2026 | Stephen Feider | Chief Financial Officer | Derivative Exercise and Sale | -10,000 | $17.05 | 166,053 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 4,980,771 | 9.2% | 3.9 |
| 15 Oct 2026 | 6,917,021 | 15.4% | 7.4 |
| 30 Sep 2026 | 6,046,389 | 13.4% | 3.3 |
| 15 Sep 2026 | 10,617,768 | 23.6% | 9.9 |
| 31 Aug 2026 | 9,400,691 | 20.9% | 9.0 |
| 14 Aug 2026 | 7,494,706 | 16.7% | 5.5 |
No comments yet — be the first to weigh in on BBNX.
Sign in to join the discussion.